-
Product Insights
NewSevere Acute Respiratory Syndrome (SARS) – Drugs In Development, 2024
Empower your strategies with our Severe Acute Respiratory Syndrome (SARS) – Drugs In Development, 2024 report and make more profitable business decisions. Severe acute respiratory syndrome (SARS) is a serious, potentially life-threatening viral infection caused by virus from the Coronaviridae family. Symptoms include cough, chills and shaking, headache, muscle aches, diarrhea, dizziness, nausea, and vomiting. Risk factors include gene variation in the immune system and close contact with someone who has SARS. The Severe Acute Respiratory Syndrome (SARS) drugs in development...
-
Product Insights
NewAvian Influenza – Drugs In Development, 2024
Empower your strategies with our Avian Influenza – Drugs In Development, 2024 report and make more profitable business decisions. Avian influenza, commonly referred to as bird flu, is a viral infection that primarily affects birds, especially poultry such as chickens and turkeys. Various strains of avian influenza viruses exist, some of which can cause severe illness in birds and, in certain cases, pose a risk to human health. Avian influenza viruses belong to the influenza A virus family and are classified...
-
Product Insights
NewInfluenza A Virus, H7N9 Subtype Infections – Drugs In Development, 2024
Empower your strategies with our Influenza A Virus, H7N9 Subtype Infections – Drugs In Development, 2024 report and make more profitable business decisions. Avian influenza A (H7N9) is a subtype of influenza viruses known as "bird flu". This infection is seen both in humans and birds. Infection is caused when a person is exposure to infected poultry or contaminated environments. Symptoms include fever, cough that produces sputum, headache, myalgia, and general malaise. Treatment includes antiviral drugs. The Influenza A Virus, H7N9...
-
Product Insights
NewGastroenteritis – Drugs In Development, 2024
Empower your strategies with our Gastroenteritis – Drugs In Development, 2024 report and make more profitable business decisions. Gastroenteritis is an infection of the gut. Symptoms include stomach pain, cramping, fever, nausea, and a headache. Causes of gastroenteritis include contaminated food or water, and contact with someone who has the virus. Treatment includes antibiotics, anti-emetic and anti-diarrheal medications. The Gastroenteritis drugs in development market research report provide comprehensive information on the therapeutics under development for Gastroenteritis, complete with analysis by stage...
-
Product Insights
NewInfluenzavirus B Infections – Drugs In Development, 2024
Empower your strategies with our Influenzavirus B Infections – Drugs In Development, 2024 report and make more profitable business decisions. Type B influenza is a subtype of the influenza virus that tends to occur sporadically. Symptoms include runny nose, sore throat, aching muscles, malaise, watery eyes, aching body, loss of appetite, and weakness. Treatment includes antivirals, analgesics, and antipyretics medications. The Influenzavirus B Infections drugs in development market research report provide comprehensive information on the therapeutics under development for Influenzavirus B...
-
Product Insights
NewInfluenzavirus A Infections – Drugs In Development, 2024
Empower your strategies with our Influenzavirus A Infections – Drugs In Development, 2024 report and make more profitable business decisions. Influenza A virus infections are caused by a type of influenza virus with a high capacity for genetic variation. It is more serious than the common cold and can cause major outbreaks and severe disease. It spreads through droplets from the nose or throat of an infected person, usually through coughing and sneezing. The proteins on the surface of the influenza...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AL-001 in Dementia Associated With Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AL-001 in Dementia Associated With Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AL-001 in Dementia Associated With Alzheimer's Disease Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AL-001 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AL-001 in Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AL-001 in Alzheimer's Disease Drug Details: Liprosal is under development for the...
-
Company Profile
Cocrystal Pharma Inc – Company Profile
Cocrystal Pharma Inc (Cocrystal Pharma), is a clinical-stage biotechnology company that discovers and develops novel antiviral therapeutics. The company provides treatments for chronic viral diseases. Its product pipeline includes CC-42344 oral PB2 inhibitor, influenza A/B inhibitor, CC-42344 inhaled PB2 inhibitor, CDI-988 oral protease inhibitor, CDI-45205 protease inhibitor, replication inhibitors, replication and protease inhibitors and others. Cocrystal Pharma offers products that include non-nucleoside inhibitors, novel pan-genotypic nucleoside prodrugs, and helicase inhibitors. The company’s novel pan-genotypic nucleoside pro-drugs are used in non-toxic,...
Add to Basket -
Product Insights
Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Middle East Respiratory Syndrome (MERS) Pipeline Drugs Market Report Overview Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERS-CoV). Symptoms include fever, cough, and shortness of breath. Other symptoms include nausea, vomiting and diarrhea. The MERS pipeline drugs market research report provides comprehensive information on the MERS targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players...